Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0000950170-24-121742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-11-05 | 2024-11-01+ | CORT | Guyer William | Chief Development Off | S - Sale+OE | $48.97 | -10.0K | 5,796 | -63% | -$489.7K |
| DMT | 2024-11-05 | 2024-11-01+ | CORT | Guyer William | Chief Development Off | M - OptEx | $21.65 | +10.0K | 12.4K | +416% | +$216.5K |
| DMT | 2024-11-05 | 2024-11-01+ | CORT | Guyer William | Chief Development Off | M - OptEx | $0.00 | -10.0K | 450.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-04 | S | D | 3,394 | $48.97 | 5,796 | D | — | — | (F1) Includes 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 2 | Common | Common Stock | 2024-11-04 | M | A | 3,394 | $21.65 | 9,190 | D | — | — | (F1) Includes 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 3 | Common | Common Stock | 2024-11-01 | S | D | 6,606 | $48.97 | 5,796 | D | — | — | (F1) Includes 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 4 | Common | Common Stock | 2024-11-01 | M | A | 6,606 | $21.65 | 12,402 | D | — | — | (F1) Includes 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 5 | Derivative | Stock option (right to buy) | 2024-11-01 | M | D | 6,606 | $0.00 | 453,394 | D | $21.65 · — to 2031-09-01 | 6,606 Common Stock | (F3) Shares subject to the stock option vested and became exercisable with respect to 25% of the shares on the first anniversary of August 16, 2021 (the "Vesting Commencement Date") with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service. |
| 6 | Derivative | Stock option (right to buy) | 2024-11-04 | M | D | 3,394 | $0.00 | 450,000 | D | $21.65 · — to 2031-09-01 | 3,394 Common Stock | (F3) Shares subject to the stock option vested and became exercisable with respect to 25% of the shares on the first anniversary of August 16, 2021 (the "Vesting Commencement Date") with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service. |